Shineco logo
SISIShineco
Trade SISI now
Shineco primary media

About Shineco

Shineco (NASDAQ:SISI) is actively engaged in the development, production, and distribution of specialized plant-based products in China. Its endeavors primarily encompass the agricultural sector, where it strives to integrate an eco-friendly approach with traditional Chinese medicinal practices. The company’s projects span from the cultivation of herbal medicines that play a crucial role in traditional treatments to the innovation in agricultural technologies aimed at enhancing sustainability and efficiency. A significant objective for Shineco is to leverage its expertise in biotechnology and environmentally conscious farming techniques to meet the growing demand for natural and health-associated products. Furthering its mission, Shineco is committed to expanding its market reach and exploring new opportunities to contribute positively to health and wellness communities.

What is SISI known for?

Snapshot

Public US
Ownership
1997
Year founded
87
Employees
Beijing, China
Head office
1 of 5
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

Products and/or services of Shineco

  • Luobuma products, focusing on healthcare benefits derived from the Apocynum plant.
  • Chinese herbal medicine manufacturing, including traditional formulas for various ailments.
  • Agricultural cultivation and processing, emphasizing eco-friendly and sustainable practices.
  • Textile products, particularly those incorporating eco-friendly materials and traditional Chinese techniques.
  • Real estate services, mainly in the development and management of commercial and residential properties.
  • Biotechnology research, aiming at advancing herbal medicine efficacy and applications.

Shineco executive team

  • Ms. Jennifer ZhanCEO & Executive Director
  • Mr. Sai WangCFO & Director
  • Mr. Xiqiao LiuCOO & Executive Director
  • Ms. Wang XiaohuiExecutive President
  • Dr. Fenming LiuChief Scientist
  • Mr. Qiyin SunChief Medical Consultant
  • Mr. Chi Keung YanChief Strategy Officer
  • Mr. Hongguang LinGM of the Biological Cell Digital Business Division

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.